Surgical correction of the genital hiatus at the time of sacrocolpopexy — a 7-year Markov analysis: a cost-effectiveness analysis
International Urogynecology Journal · 2023
DOI: 10.1007/s00192-023-05628-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urogynecology Journal, 2023. Verfasst von Olivia H Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Female Urology, Pelvic Reconstructive Surgery & Voiding Dysfunction, Department of Urology, University of California Irvine, 3800 W. Chap…. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Dyspareunia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Foundation for female health awareness.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: To perform a cost-effectiveness analysis of concurrent posterior repair performed at the time of laparoscopic hysterectomy with sacrocolpopexy over a 7-year time period. We hypothesize it is not cost-effective to perform a posterior colporrhaphy. METHODS: We used TreeAge Pro® to construct a decision model with Markov modeling to compare sacrocolpopexy with and without concurrent posterior repair (SCP and SCP+PR) over a time horizon of 7 years. Outcomes included probability and costs associated with prolapse recurrence, prolapse retreatment, and complications including rectal injury, rectovaginal hematoma requiring reoperation, and postoperative dyspareunia. Cost-effectiveness was defined as an incremental cost-effectiveness ratio (ICER) calculated as ∆ costs /∆ effectiveness and the willingness to pay (WTP) was set at $100,000/QALY. RESULTS: Our model showed that SCP was the dominant strategy, with lower costs (-$ 2681.06) and higher effectiveness (+0.10) compared to SCP+PR over the 7-year period. In two-way sensitivity analyses, we varied the probability of prolapse recurrence after both strategies. Our conclusions would only change if the probability of recurrence after SCP was at least 29.7% higher than after SCP+PR. When varying the probabilities of dyspareunia for both strategies, SCP+PR only became the dominant strategy if the probability of dyspareunia for SCP+PR was lower than the rate of SCP alone. CONCLUSIONS: In this 7-year Markov cost-effectiveness analysis, SCP without concurrent PR was the dominant strategy. SCP+PR costs more with lower effectiveness than SCP alone, due to higher surgical cost of SCP+PR and higher probability of dyspareunia after SCP+PR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Female Urology, Pelvic Reconstructive Surgery & Voiding Dysfunction, Department of Urology, University of California Irvine, 3800 W. Chapman St, Suite 7200, Orange, CA, 92868, USA. OliviaChangMD@gmail.com.
- Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, CT, USA.
- Urogynecology and Reconstructive Pelvic Surgery, Yale School of Medicine, New Haven, CT, USA.
- Urogynecology and Pelvic Reconstructive Surgery, Stanford University School of Medicine, Stanford, CA, USA.
- Center for Urogynecology and Pelvic Reconstructive Surgery, Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA.
ORCID-Profile: Olivia H Chang
Förderung
- Foundation for female health awareness
Zitieren
APA
Chang, O. H., Shepherd, J. P., St Martin, B., Sokol, E. R., & Wallace, S. (2023). Surgical correction of the genital hiatus at the time of sacrocolpopexy — a 7-year Markov analysis: a cost-effectiveness analysis. International Urogynecology Journal. https://doi.org/10.1007/s00192-023-05628-9
Vancouver
Chang OH, Shepherd JP, St Martin B, Sokol ER, Wallace S. Surgical correction of the genital hiatus at the time of sacrocolpopexy — a 7-year Markov analysis: a cost-effectiveness analysis. International Urogynecology Journal. 2023. doi:10.1007/s00192-023-05628-9
BibTeX
@article{Chang2023,
author = {Chang, Olivia H and Shepherd, Jonathan P and St Martin, Brad and Sokol, Eric R and Wallace, Shannon},
title = {Surgical correction of the genital hiatus at the time of sacrocolpopexy — a 7-year Markov analysis: a cost-effectiveness analysis},
journal = {International Urogynecology Journal},
year = {2023},
doi = {10.1007/s00192-023-05628-9}
}
EUVIMED